US Edition
News from citybiz
If you want to know if Citybiz is credible or reliable, look no further. We rank Citybiz as Unknown factuality. Find out more about our methodology here.
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Citybiz News
US Economy · United StatesHuntington Bancshares is buying regional bank Cadence Bank in an all-stock deal valued at $7.4 billion that will strengthen its position across the Southern U.S. Cadence, which has headquarters in Houston, Texas and Tupelo, Mississippi, has more than 390 locations across Texas and the South. It runs branches across Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, Missouri, Tennessee, and Texas.
See the Story
Huntington Bancshares buying Cadence Bank in $7.4 billion all-stock deal
63% Center coverage: 27 sources
Cambridge, Massachusetts · CambridgeCAMBRIDGE, Mass., Oct. 28, 2025 /PRNewswire/ -- Pinetree Therapeutics, a preclinical-stage biotechnology company pioneering targeted protein degraders for drug-resistant cancers, announced the successful closing of an oversubscribed $47 million Series B financing. The proceeds will advance its lead preclinical oncology…See the Story
Pinetree Therapeutics Raises $47 Million in Oversubscribed Series B to Advance Next-Generation Protein Degraders in Oncology
70% Center coverage: 20 sources
